Review
Copyright ©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Nov 21, 2008; 14(43): 6627-6631
Published online Nov 21, 2008. doi: 10.3748/wjg.14.6627
Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?
Ijaz S Jamall, Shafaq Yusuf, Maimoona Azhar, Selene Jamall
Ijaz S Jamall, Risk-Based Decisions, Inc., 2033 Howe Avenue, Suite 240, Sacramento, California 95825, United States
Shafaq Yusuf, Maimoona Azhar, Dow Medical College and Civil Hospital, Karachi, 74000, Pakistan
Selene Jamall, University of California-San Diego, La Jolla, CA 92092, United States
Author contributions: Jamall IS developed the approach and hypothesis and wrote much of the initial draft; Yusuf S and Azhar M provided clinical experience and relevance; Jamall S was a student intern with RBDI who conducted the literature search, data evaluation and helped in the writing of the final manuscript.
Supported by Risk-Based Decisions, Inc
Correspondence to: Ijaz S Jamall, Risk-Based Decisions, Inc., 2033 Howe Avenue, Suite 240, Sacramento, California 95825, United States. ijamall@riskbaseddecisions.com
Telephone: 001-916-923-0570 Fax: 001-916-923-0611
Received: August 5, 2008
Revised: November 12, 2008
Accepted: November 19, 2008
Published online: November 21, 2008
Core Tip